Severe adverse events during antiviral therapy in hepatitis C virus cirrhotic patients: A systematic review.

Severe adverse events during antiviral therapy in hepatitis C virus cirrhotic patients: A systematic review.

Item
http://www.wikidata.org/entity/Q33406835
Simeprevir-Based Triple Therapy with Reduced Doses of Pegylated Interferon α-2a Plus Ribavirin for Interferon Ineligible Patients with Genotype 1b Hepatitis C Virus.Impaired expression of type I and type II interferon receptors in HCV-associated chronic liver disease and liver cirrhosis.Cost-effectiveness of sofosbuvir in the treatment of patients with hepatitis CHealth state utilities associated with attributes of treatments for hepatitis C.Low-Dose Pegylated Interferon α-2b Plus Ribavirin for Elderly and/or Cirrhotic Patients with Genotype 2 Hepatitis C Virus.Hepatitis C-related liver cirrhosis - strategies for the prevention of hepatic decompensation, hepatocarcinogenesis, and mortalityDaclatasvir plus asunaprevir for HCV genotype 1b infection in patients with or without compensated cirrhosis: a pooled analysis.Management of HCV in cirrhosis-a rapidly evolving landscape.Infectious Considerations in the Pre-Transplant Evaluation of Cirrhotic Patients Awaiting Orthotopic Liver Transplantation.Real-world efficacy and safety of daclatasvir and asunaprevir therapy for hepatitis C virus-infected cirrhosis patients.Sustained virological response to ombitasvir/paritaprevir/ritonavir and dasabuvir treatment for hepatitis C: Real-world data from a large healthcare provider.Interleukin 28B polymorphism predicts interferon plus ribavirin treatment outcome in patients with hepatitis C virus-related liver cirrhosis: A multicenter retrospective study in Japan.Peginterferon still has a place in the treatment of hepatitis C caused by genotype 3 virus.
P2860

Severe adverse events during antiviral therapy in hepatitis C virus cirrhotic patients: A systematic review.

Item
http://www.wikidata.org/entity/Q33406835
description
2013 nî lūn-bûn
@nan
2013 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի մարտին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Severe adverse events during a ...... patients: A systematic review.
@ast
Severe adverse events during a ...... patients: A systematic review.
@en
type
label
Severe adverse events during a ...... patients: A systematic review.
@ast
Severe adverse events during a ...... patients: A systematic review.
@en
prefLabel
Severe adverse events during a ...... patients: A systematic review.
@ast
Severe adverse events during a ...... patients: A systematic review.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P698
P921
P932
P356
P1433
P1476
Severe adverse events during a ...... patients: A systematic review.
@en
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P698
P921
P932